What type of cancer is Rubraca used to treat?
Medically reviewed by Judith Stewart, BPharm. Last updated on Sep 30, 2020.
Rubraca (rucaparib) is used for the treatment of certain types of ovarian cancer and prostate cancer.
Rubraca belongs to the class of drugs called poly (ADP-ribose) polymerase (PARP) inhibitors which are targeted therapies used in the treatment of certain types of cancer.
Rubraca is used for the treatment of ovarian cancer, fallopian tube cancer, or primary peritoneal cancer in patients who have a germline (inherited) and/or somatic (acquired) abnormal BRCA gene, and who have been treated with two or more types of chemotherapy.
Rubraca is also used for the maintenance treatment of ovarian cancer, fallopian tube cancer, or primary peritoneal cancer that has returned in patients who have received platinum-based chemotherapy.
Rubraca is used for the treatment of metastatic (has spread to other parts of the body) castration-resistant prostate cancer (prostate cancer that no longer responds to medical or surgical treatment that lowers testosterone) in patients that have a germline and/or somatic abnormal BRCA gene who have been treated with androgen receptor-directed therapy and a taxane-based chemotherapy.
Related Medical Questions
- What is the difference between Yonsa and Zytiga?
- What type of prostate cancer is Erleada used to treat?
- What type of drug is Zejula?
- What is the lifetime or cumulative dose for Adriamycin?
- What are the long-term side effects of Adriamycin?